Investment Rating - The investment rating for the company is 5.5 out of 10, based on operational performance, industry outlook, valuation, and market sentiment [8]. Core Insights - The company is a leading supplier in China focused on chemical new materials and gelatin, with over 95% of its revenue coming from the large chemical sector. It ranks as the second-largest in organic polymer modified materials and organic polymer composite materials in China, holding a market share of 2.5% [1]. - The company has shown steady revenue growth, with projected revenues of approximately RMB 134.1 billion, 174.4 billion, and 191.9 billion for the years 2022, 2023, and 2024 respectively. In the first ten months of 2025, revenue reached RMB 174.4 billion, reflecting a year-on-year increase of 10% [1]. - The net profit attributable to shareholders for 2022, 2023, and 2024 was RMB 6.63 billion, 4.71 billion, and 6.85 billion respectively, with a significant increase of 40% year-on-year to RMB 7.12 billion in the first ten months of 2025 [1]. Company Overview - The company specializes in green petrochemical materials, including aromatic olefins, styrene, polystyrene, and organic polymer modified materials, which are applied in automotive, new energy, and home appliance sectors. It also operates in the health sector, producing gelatin, collagen, and hollow capsules [1]. - The global market for organic polymer modified materials and organic polymer composite materials is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2029, with China projected to grow at 14.1% [2]. Advantages and Opportunities - The company has established a strong market position in the organic polymer modified materials sector through a vertically integrated model and strategic expansion into the health sector, creating a dual growth engine under its "one body, two wings" strategy [3]. - It has a robust research and development capability, a strong reputation, and long-term partnerships with leading enterprises, supported by a visionary and experienced management team [3].

Investment Rating - The report recommends subscription for the company, Guo'en Technology, with an IPO price range of HKD 34 to HKD 42 per share, suggesting a valuation of approximately 15 times the net profit for 2024 [2][3]. Core Insights - Guo'en Technology is a Chinese supplier focused on chemical new materials and gelatin, serving both the chemical and health industries. It ranks as the second-largest organic polymer modified materials and composite materials company in China by sales revenue, with a market share of 2.5% [2]. - The global polymer materials market is projected to grow from RMB 298.9 billion in 2020 to RMB 456.1 billion by 2024, with a compound annual growth rate (CAGR) of 11.1%. The Chinese polymer materials market is expected to expand from RMB 110.8 billion in 2020 to RMB 162.8 billion in 2024, with a CAGR of 10.1% [2]. - The company's revenue for 2022, 2023, and 2024 is forecasted to be RMB 13,406.4 million, RMB 17,438.8 million, and RMB 19,187.5 million, respectively, reflecting a CAGR of 19.6%. Net profits for the same years are projected at RMB 663.11 million, RMB 465.89 million, and RMB 676.38 million [3]. Summary by Sections Company Overview - Guo'en Technology specializes in the research, production, and sales of industrial and commercial products related to chemical new materials and gelatin [2]. Market Position - The company is the second-largest producer of bone gelatin and the second-largest domestic brand producer of hollow capsules in China [2]. Financial Performance - The company’s revenue and net profit projections indicate a strong growth trajectory, with significant increases expected in the coming years [3].

Investment Rating - The report recommends subscription for the company, Guo'en Technology, with an IPO price range of HKD 34 to HKD 42 per share, suggesting a valuation of approximately 15 times the net profit for 2024 [3]. Core Insights - Guo'en Technology is a Chinese supplier focused on chemical new materials and gelatin, serving both the chemical and health industries. It ranks as the second-largest organic polymer modified materials and composite materials company in China by sales revenue, with a market share of 2.5% [2]. - The global polymer materials market is projected to grow from RMB 29.89 trillion in 2020 to RMB 45.61 trillion by 2024, with a compound annual growth rate (CAGR) of 11.1%. The Chinese polymer materials market is expected to expand from RMB 11.08 trillion in 2020 to RMB 16.28 trillion by 2024, with a CAGR of 10.1% [2]. - The company's revenue for 2022, 2023, and 2024 is forecasted to be RMB 13.41 billion, RMB 17.44 billion, and RMB 19.19 billion, respectively, reflecting a CAGR of 19.6%. Net profits for the same years are projected at RMB 663.11 million, RMB 465.89 million, and RMB 676.38 million [3]. Summary by Relevant Sections IPO Details - The IPO is set to raise HKD 10.577 billion, with a total offering of 30 million shares, of which 27 million shares are allocated for international placement and 3 million shares for public offering [1]. Market Position - Guo'en Technology is the second-largest producer of bone gelatin and the second-largest domestic brand producer of hollow capsules in China, indicating a strong market presence [2]. Financial Performance - The company is currently in a stable growth phase, with a significant safety margin in its valuation based on the IPO pricing compared to its A-share closing price [3].

Group 1 - The core viewpoint of the news is that Guoen Technology (国恩科技) is preparing for its IPO in the Hong Kong market, with a strong foundation and significant fundraising expectations [2][4] - Guoen Technology plans to globally issue approximately 30 million H-shares, with 3 million shares allocated for public offering in Hong Kong and 27 million shares for international offering [2] - The expected net fundraising amount is approximately HKD 1.058 billion, with funds allocated for expanding production capacity in Thailand and China, as well as for operational purposes [2][4] Group 2 - Guoen Technology specializes in new chemical materials and collagen products, serving the chemical and health industries, focusing on R&D, production, and sales [4] - The company ranks second in the organic polymer modification and composite materials industry in China by sales revenue, with a market share of 2.5%, and is the largest producer of polystyrene in China [4] - In the health sector, Guoen Technology's subsidiary, Dongbao Biological, has established a complete layout from collagen raw materials to end products, becoming a comprehensive group in the health segment [4] Group 3 - For the fiscal years 2022 to 2024, Guoen Technology's revenues were RMB 13.406 billion, RMB 17.439 billion, and RMB 19.188 billion, with corresponding profits of RMB 0.724 billion, RMB 0.540 billion, and RMB 0.721 billion [5] - The company has shown solid performance in its financial results, indicating a stable growth trajectory [5]

Core Viewpoint - The company, Guoen Technology (02768), is set to launch an IPO from January 27 to January 30, 2026, offering 30 million shares globally, with a price range of HKD 34.00 to HKD 42.00 per share, and aims to raise approximately HKD 1.058 billion for capacity expansion and operational purposes [1][5]. Group 1: Company Overview - Guoen Technology specializes in chemical new materials and gelatin, collagen, and related products, serving both the chemical and health industries [1]. - The company focuses on R&D, production, and sales of industrial and commercial products, catering to manufacturers in downstream sectors such as automotive, new energy, and home appliances [1]. Group 2: Chemical Industry Segment - In the chemical industry, the company has a comprehensive product range that includes upstream green petrochemical materials and midstream organic polymer modified materials [2]. - The company is the second-largest player in China's organic polymer modified materials and organic polymer composite materials market, with a market share of 2.5% as of 2024 [2]. - It is also the largest producer of polystyrene in China by capacity as of 2024 [2]. Group 3: Health Industry Segment - In the health sector, the company focuses on the natural collagen industry and has established a vertically integrated product line from collagen to end products [3]. - The company ranks second in China's bone gelatin production by output and is the leading domestic brand in this category as of 2024 [3]. - It is also the second-largest domestic brand in the hollow capsule production market by output as of 2024 [3]. Group 4: Investment and Fund Allocation - The company has secured cornerstone investment agreements totaling approximately HKD 320 million, with key investors including Liguang Investment and others [4]. - The net proceeds from the IPO are expected to be around HKD 1.058 billion, with allocations of 50% for expanding production capacity in Thailand, 35% for capacity expansion in China, 10% for investments in Hong Kong, and 5% for operational funds [5].

Core Viewpoint - The company, Guo'en Technology, is set to launch an IPO from January 27 to January 30, 2026, offering 30 million shares globally, with a price range of HKD 34.00 to HKD 42.00 per share, and aims to raise approximately HKD 1.058 billion for expansion and operational purposes [1][5]. Group 1: Company Overview - Guo'en Technology specializes in chemical new materials and gelatin, collagen, and related products, serving both the chemical and health industries [1]. - The company focuses on R&D, production, and sales of industrial and commercial products, catering to manufacturers in downstream sectors such as automotive, new energy, and home appliances [1]. Group 2: Chemical Industry Segment - In the chemical industry, the company has a comprehensive product range that includes upstream green petrochemical materials and midstream organic polymer modified materials [2]. - The company is the second-largest player in China's organic polymer modified materials and organic polymer composite materials market, with a market share of 2.5% as of 2024 [2]. - It is also the largest producer of polystyrene in China by production capacity as of 2024 [2]. Group 3: Health Industry Segment - In the health sector, the company focuses on the natural collagen industry, with a vertical integration strategy that spans from collagen to end products [3]. - The company is the second-largest producer of bone gelatin in China by output and the largest domestic brand in this category as of 2024 [3]. - It ranks as the second-largest domestic brand in the hollow capsule production sector in China by output as of 2024 [3]. Group 4: Investment and Fund Allocation - The company has secured cornerstone investment agreements totaling approximately HKD 320 million, with investors including several financial institutions [4]. - The net proceeds from the IPO are expected to be around HKD 1.058 billion, with allocations planned for expanding production capacity in Thailand (50%), China (35%), and investments in Hong Kong (10%) [5].

Group 1 - The company, Guoen Technology (02768.HK), plans to globally offer 30 million H-shares, with 3 million shares available in Hong Kong and 27 million shares for international distribution, with the offering period from January 27 to January 30, 2026, and expected pricing on February 2, 2026 [1] - The expected share price range is between HKD 34.00 and HKD 42.00, with a trading unit of 200 shares, and the shares are anticipated to start trading on the Hong Kong Stock Exchange on February 4, 2026 [1] - Guoen Technology specializes in chemical new materials and gelatin, collagen, and related products, serving the chemical and health industries, focusing on R&D, production, and sales [1] Group 2 - The company has entered into cornerstone investment agreements, with cornerstone investors agreeing to subscribe for shares totaling approximately HKD 320 million, assuming a maximum share price of HKD 42.00 [2] - The cornerstone investors include several entities such as Liguan Investment Limited, SLD International Enterprises Limited, and others [2] Group 3 - Assuming a mid-range share price of HKD 38.00, the company estimates net proceeds from the global offering to be approximately HKD 1.0577 billion [3] - The company plans to allocate about 50% or HKD 528.5 million to establish a new production base in Thailand to expand capacity, 35% or HKD 370.5 million to enhance capacity at its Yixing production base, and 10% or HKD 105.7 million for investments in Hong Kong [3] - The remaining 5% or approximately HKD 53 million is expected to be used for working capital and general corporate purposes [3]

Group 1 - The core viewpoint of the article is that Qingdao Guoen Technology Co., Ltd. has passed the listing hearing on the Hong Kong Stock Exchange, with China Merchants Securities International as the sole sponsor, focusing on new chemical materials and gelatin, collagen products [1] Group 2 - Guoen Technology serves the chemical and health industries, engaging in the R&D, production, and sales of products for industrial and commercial use [3] - The company has a diverse client base, including manufacturers in downstream industries such as automotive, new energy, and home appliances, as well as medical and pharmaceutical manufacturers in the health sector [3] - Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials by sales revenue, holding a market share of 2.5% in 2024 [3] - The company is also the largest producer of polystyrene in China by production capacity in 2024 [3] Group 3 - Guoen Technology focuses on the natural collagen industry, with its subsidiary Dongbao Biological leveraging a vertical integration strategy to cover the entire value chain from collagen to end products [4] - The company is the second-largest producer of bone gelatin in China by production volume and the second-largest domestic brand in the hollow capsule industry by production volume in 2024 [5] Group 4 - The market size for organic polymer modified materials and organic polymer composite materials is projected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion in 2024, with a compound annual growth rate (CAGR) of 15.7% [5] - Guoen Technology's revenues for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 are approximately RMB 13.41 billion, RMB 17.44 billion, RMB 19.19 billion, and RMB 17.44 billion respectively [5][6] - The company's net profits for the same periods are approximately RMB 724 million, RMB 540 million, RMB 721 million, and RMB 721 million [5][6]

Company Overview - Guoen Technology is a Chinese supplier focused on new chemical materials and gelatin, collagen upstream and downstream products, serving the chemical and health industries [4] - The company engages in research, production, and sales of products for industrial and commercial use, with clients including manufacturers in automotive, new energy, and home appliances [4] - In the health sector, Guoen Technology's clients include medical and pharmaceutical manufacturers who use its products as raw materials for supplements and medications [4] Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest organic polymer modified materials and organic polymer composite materials company in China by sales revenue, with a market share of 2.5% in 2024 [5] - The company is the largest polystyrene producer in China by production capacity in 2024 [5] - In the health sector, Guoen Technology is the second-largest bone gelatin producer in China by output and the largest domestic brand in the same category [5] Financial Performance - The company reported revenues of approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion for the fiscal years 2022, 2023, 2024, and the first ten months of 2025, respectively [6] - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [7] - The return on equity for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 was 12.3%, 8.5%, 10.2%, and 9.5%, respectively [10] Industry Overview - The global polymer materials market is projected to grow from RMB 298.9 billion in 2020 to RMB 456.15 billion in 2024, with a compound annual growth rate (CAGR) of 11.1% [12] - China's polymer materials market is expected to expand from RMB 110.8 billion in 2020 to RMB 162.8 billion in 2024, with a CAGR of 10.1% [12] - The organic polymer modified materials and organic polymer composite materials market is anticipated to grow from RMB 84.81 billion in 2020 to RMB 150.38 billion in 2024, with a CAGR of 15.4% [14]

Company Overview - Guoen Technology is a Chinese supplier focused on new chemical materials and upstream and downstream products of gelatin and collagen, serving the chemical and health industries [4] - The company has a diverse customer base, including manufacturers in the automotive, new energy, and home appliance sectors, as well as medical and pharmaceutical manufacturers in the health sector [4] Market Position - According to Frost & Sullivan, Guoen Technology is the second-largest company in China for organic polymer modified materials and organic polymer composite materials by sales revenue, with a market share of 2.5% in 2024 [5] - The company is also the largest producer of polystyrene in China by production capacity in 2024 [5] - In the health sector, Guoen Technology's subsidiary Dongbao Bio has established a comprehensive product layout from collagen peptides to end products, becoming a significant player in the health industry [5] Financial Performance - The company reported revenues of approximately RMB 134.06 billion, RMB 174.39 billion, RMB 191.88 billion, and RMB 174.44 billion for the fiscal years 2022, 2023, 2024, and the first ten months of 2025, respectively [6] - The net profit for the same periods was RMB 7.24 billion, RMB 5.4 billion, RMB 7.21 billion, and RMB 7.21 billion [7] - The return on equity for the fiscal years 2022, 2023, 2024, and the first ten months of 2025 was 12.3%, 8.5%, 10.2%, and 9.5%, respectively [9] Industry Overview - The global polymer materials market is expected to grow from RMB 298.9 billion in 2020 to RMB 456.15 billion in 2024, with a compound annual growth rate (CAGR) of 11.1% from 2020 to 2024 [11] - China's polymer materials market is projected to expand from RMB 110.8 billion in 2020 to RMB 162.8 billion in 2024, with a CAGR of 10.1% [11] - The market for organic polymer modified materials and organic polymer composite materials in China is expected to grow from RMB 303.8 billion in 2020 to RMB 544.8 billion in 2024, with a CAGR of 15.7% [14]